Stockscreener 앱 받기
28.79
0.17%
-0.05
시간 외 거래:
29.00
0.21
+0.73%
전일 마감가:
$28.84
열려 있는:
$28.94
하루 거래량:
67,941
Relative Volume:
0.64
시가총액:
$1.03B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+9.43%
1개월 성능:
+9.89%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$28.74
$29.34
1주일 범위
$26.71
$29.34
52주 변동 폭
$24.10
$29.53
Ceribell Inc Stock (CBLL) Company Profile
명칭
Ceribell Inc
전화
(800) 436-0826
주소
360 N. PASTORIA AVENUE, SUNNYVALE
CBLL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
28.79 | 1.03B | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
118.77 | 206.00B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
392.15 | 149.49B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.66 | 133.62B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
86.54 | 110.97B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.35 | 42.08B | 6.60B | 4.16B | 490.10M | 6.93 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-05 | 개시 | BofA Securities | Buy |
| 2024-11-05 | 개시 | Canaccord Genuity | Buy |
| 2024-11-05 | 개시 | JP Morgan | Overweight |
| 2024-11-05 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 개시 | William Blair | Outperform |
Ceribell Inc 주식(CBLL)의 최신 뉴스
CeriBell: Healthcare Technology Stock With A Promising Growth Outlook (NASDAQ:CBLL) - Seeking Alpha
Ceribell appoints Rodenbush as CPO, Price as SVP of Marketing - TipRanks
Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing - The Manila Times
Ceribell Strengthens Leadership Team with Key AI Medical Device Executives | CBLL Stock News - StockTitan
Meet the biophysicist whose seizure-detection company is using AI to get a better read on people's brains - Fast Company
FY2024 EPS Estimates for CeriBell Reduced by William Blair - MarketBeat
William Blair Estimates CeriBell's Q1 Earnings (NASDAQ:CBLL) - MarketBeat
Ceribell revenue increases 48% to USD 17.2M in Q3 2024 - Medical Buyer
Ceribell, Inc. Reports Strong Q3 2024 Growth - Yahoo Finance
Ceribell price target raised to $31 from $30 at Canaccord - TipRanks
CeriBell (NASDAQ:CBLL) Price Target Raised to $31.00 at Canaccord Genuity Group - MarketBeat
CeriBell's (NASDAQ:CBLL) Quiet Period To End on November 20th - MarketBeat
CeriBell’s Quiet Period To End on November 20th (NASDAQ:CBLL) - Defense World
Ceribell Reports Third Quarter 2024 Financial Results - GlobeNewswire
CeriBell, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs - GlobeNewswire
Ceribell Secures VA Authorization, Expands AI-Powered EEG Tech to Veterans Hospitals | CBLL Stock News - StockTitan
Q3 Earnings Estimate for CeriBell Issued By William Blair - Defense World
Brokerages Set CeriBell (NASDAQ:CBLL) PT at $31.00 - Defense World
Ceribell started with bullish ratings by J.P. Morgan, Canaccord - MSN
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - The Manila Times
FMR LLC Acquires New Stake in CeriBell Inc - GuruFocus.com
Ceribell initiated with a Buy at BofA on ‘differentiated AI algorithm’ - Yahoo Finance
Ceribell stock a buy as JPMorgan highlights disruptive tech in $3B seizure market - Investing.com Australia
Ceribell initiated with an Overweight at JPMorgan - MSN
Ceribell started with bullish ratings by J.P. Morgan, Canaccord (NASDAQ:CBLL) - Seeking Alpha
TD Cowen starts coverage on Ceribell stock with Buy, highlights innovative tech - Investing.com Canada
This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
A&O Shearman advises on initial public offering of Ceribell, Inc. - A&O Shearman
Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024 - WV News
Ceribell’s stock soars 36% in trading debut after pricing IPO at top of range - MSN
Septerna Shares Jump 19% After IPO Shows Biotech Still Hot - Bloomberg
CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs - MSN
CeriBell: An Interesting EEG Play Going Public (NASDAQ:CBLL) - Seeking Alpha
TPG GP A, LLC Acquires New Stake in CeriBell Inc - GuruFocus.com
Ceribell EEG system linked to improved patient outcomes - Investing.com India
Ceribell EEG system linked to improved patient outcomes By Investing.com - Investing.com Australia
Ceribell director Juliet Tammenoms Bakker buys $4.03m in stock By Investing.com - Investing.com Australia
Ceribell director Juliet Tammenoms Bakker buys $4.03m in stock - Investing.com
New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG - PR Newswire
CeriBell closes upsized IPO - Medical Buyer
Ceribell Inc (CBLL) 재무 분석
Ceribell Inc (CBLL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.73%
0.14%
자본화:
|
볼륨(24시간):